XCUR Stock Summary and Trading Ideas (Exicure | NASDAQ:XCUR)

Exicure Inc is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. It operates in a single segment which is Biotechnology.

Exicure trades on the NASDAQ stock market under the symbol XCUR.

As of December 5, 2025, XCUR stock price declined to $4.90 with 156,743 million shares trading.

XCUR has a beta of 0.65, meaning it tends to be less sensitive to market movements. XCUR has a correlation of 0.01 to the broad based SPY ETF.

XCUR has a market cap of $31.23 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, XCUR traded as high as $36.00 and as low as $1.44.

The top ETF exchange traded funds that XCUR belongs to (by Net Assets): VXF, IWC.

XCUR has underperformed the market in the last year with a return of -78.6%, while the SPY ETF gained +14.2%. In the last 3 month period, XCUR fell short of the market, returning +3.2%, while SPY returned +6.2%. However, in the most recent 2 weeks XCUR has outperformed the stock market by returning +17.5%, while SPY returned +4.0%.

XCUR support price is $6.08 and resistance is $7.40 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that XCUR shares will trade within this expected range on the day.